Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin

Eye

Volumn 23, Issue 12, 2009, Pages 2260-2262

  Wefers Bettink Remeijer, M ^a   Brouwers, K ^b   Van Langenhove, L ^b   De Waard, P W T ^a   Missotten, T O ^a   Martinez Ciriano, J P ^a   Van Aken, E ^c  

^a ROTTERDAM EYE HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Adverse effect; Iris transillumination; Moxifloxacin; Sphincter paralysis; Uveitis

Indexed keywords

MOXIFLOXACIN; PREDNISONE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; GONIOSCOPY; HERPES SIMPLEX; HUMAN; IRIS DISEASE; IRIS TRANSILLUMINATION; MALE; MYDRIASIS; OUTCOME ASSESSMENT; PHOTOPHOBIA; SLIT LAMP; UVEITIS; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; FEMALE; HUMANS; IRIS DISEASES; MALE; PHOTOPHOBIA; QUINOLINES; TRANSILLUMINATION; UVEITIS;

EID: 72749101734     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.234     Document Type: Article

References (6)

1. Siefert HM, Kohlsdorfer C, Steinke W, Witt A. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. J Antimicrob Chemother 1999; 43(suppl B): 61-67.
2. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM et al. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 2005; 123: 39-44.
3. Bringas Calvo R, Iglesias Cortinas D. Acute and bilateral uveitis secondary to moxifloxacin. Arch Soc Esp Oftalmol 2004; 79: 357-359.
4. De Groot-Mijnes JD, Rothova A, Van Loon AM, Schuller M, Ten Dam-Van Loon NH, De Boer JH et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol 2006; 141: 313-318.
5. Hamanaka H, Mizutani H, Asahig K, Shimizu M. Melanocyte melanin augments sparfloxacin-induced phototoxicity. J Dermatol Sci 1999; 21: 27-33.
6. Dayhaw-Barker P. Retinal pigment epithelium melanin and ocular toxicity. Int J Tox 2002; 21(6): 451-454.